-
Because No Antidote For Eliquis Is Available To Reverse The Effects Of Anticoagulation, There Have Been Irreversible Life-Threatening And Fatal Bleeding Events
A Reversal Agent For Eliquis Currently Under Development Comes Too Late For People With Trauma-Induced Bleeding Incidents, Some Who Bled To Death (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________ UPDATE: Eliquis Antidote Will Come Too Late For…
-
Xarelto: Drug-Induced Liver Injury Warning Should Be Added To Drug Label Prescribing Information For Xarelto Say Medical Researchers
Medical Journal Article Reports On Two Patients Who Experienced Severe Liver Damage Onset During Xarelto Treatment (Posted by Tom Lamb at DrugInjuryWatch.com) Most adverse drug reaction case reports associated with the still relatively new anticoagulant Xarelto (rivaroxaban)…
-
The Link Between Popular Erectile Dysfunction (ED) Drug Viagra And Melanoma Has A Potential Molecular Basis According To Medical Expert Who Reviewed Recent Study
Finding Applies Also To ED Drugs Cialis, Levitra, Staxyn, and Stendra, As Well As Pulmonary Arterial Hypertension (PAH) Medications Revatio And Adcirca (Posted by Tom Lamb at DrugInjuryWatch.com) About six months ago we posted this item, "Viagra…
-
Some Patients Who Stopped Taking Cymbalta Have Suffered From Extended And Severe Withdrawal Reactions Without Warning
Cymbalta Discontinuation Syndrome / Symptoms Include "Brain Zaps", Extreme Mood Swings (anger, irritability), And Neurological Or Physical Problems (Posted by Tom Lamb at DrugInjuryWatch.com) While generally thought of as an antidepressant drug, Cymbalta (duloxetine) from Eli Lilly…
-
Mirapex / Requip / Neupro: Significant Increased Risk Of Compulsive Behaviors — Gambling, Shopping, And Sex — For These Parkinsons And Restless Leg Drugs
These Impulse Side Effects, As Seen In Adverse Drug Events Reports, Are Much Higher Than Previously Thought According To New Medical Journal Article (Posted by Tom Lamb at DrugInjuryWatch.com)Thomas Moore, A.B., a senior scientist at the Institute of…
-
European Medicines Agency (EMA) Committee Recommends Further Restrictions On Use Of Depakote / Depakene / Depacon By Women Of Childbearing Age
Cites Higher Risks Of Neural Tube Defects Like Spina Bifida, Hypospadias, And Other Birth Defects As Well As Increased Risk Of Autism Spectrum Disorder (Posted by Tom Lamb at DrugInjuryWatch.com)More restrictions of the use of valproate drugs…